MSD to invest in Tipperary plant
US drug company MSD is set to invest €40 million in its manufacturing facility in Co Tipperary this year, as it installs new technology used to improve a number of products. The investment will bring the total MSD has spent over a three-year period upgrading the Tipperary facility to €75 million.
New technology being installed includes a spray drying facility, which is used in the production of a number of new products to increase their solubility and improve how they are absorbed by patients. The MSD plant has been operating for 41 years and exports to 30 countries, including destinations in Europe as well as the US and Japan.
Ger Carmody, the site lead at the MSD plant in Ballydine, said the investment reflects the growing importance of MSD Ireland’s operations in the group’s global network. He said the workforce at the plant was “leading the way” in the development of new medicines including MSD’s treatment for Hepatitis C, which is being manufactured at the factory.
The company employs more than 1,800 people in Ireland across its facilities here, which include manufacturing, commercial, global finance services, and marketing.